GE HealthCare Touts Perinatal AI Platform
GE HealthCare is promoting its “Care Intellect for Perinatal,” an AI-powered platform positioned to deliver "smarter, safer births." The system is designed to provide real-time data analysis, risk stratification, and clinical decision support for maternity care teams.
Launched in October 2025, the CareIntellect for Perinatal platform was developed in collaboration with HCA Healthcare, incorporating feedback from 29 physicians and 85 nurses across 12 hospitals. The cloud-based system, which runs on Amazon Web Services, integrates key data points like fetal heart rate, blood pressure, and uterine activity into a single chronological view to reduce cognitive overload for clinical staff. This type of technology enters a U.S. healthcare landscape with the highest maternal mortality rate among high-income nations, at 22 deaths per 100,000 live births in 2022. For Black women, the rate is significantly higher, and over 80% of all maternal deaths in the country are considered preventable. The platform aims to streamline workflows amidst significant workforce shortages. Nearly half of U.S. counties are classified as "maternity care deserts," lacking a single obstetrician, midwife, or birthing facility. The country is projected to meet only 82% of the demand for OB-GYNs by 2037, while 23 states have policies that inhibit midwives from practicing to the full extent of their training. AI applications in maternal health are increasingly focused on early risk detection for conditions like preeclampsia, gestational diabetes, and preterm birth. Machine learning algorithms analyze vast datasets from patient records, fetal monitoring, and ultrasounds to identify patterns and flag potential complications sooner than might be apparent to human clinicians. For midwives, such technology could augment clinical decision-making and improve efficiency. Studies have shown AI can empower nurse-midwives to perform tasks like ultrasound scans for gestational age with accuracy comparable to trained sonographers, potentially expanding access to care in underserved areas. The global market for clinical perinatal software was valued at nearly $170 million in 2024 and is projected to grow, spurred by the need to address issues like natal mortality and preterm births through better diagnostic and obstetric tools.
